about
Metabolic factors associated with risk of renal cell carcinomaAn investigation into the relationship between statins and cancer using population-based data.Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study.Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrationsTotal serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can)Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.Metabolic risk score and cancer risk: pooled analysis of seven cohortsAssociation between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancerProspective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.Pooled cohort study on height and risk of cancer and cancer death.International cancer seminars: a focus on kidney cancer.Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project.Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.Metabolic syndrome and rare gynecological cancers in the metabolic syndrome and cancer project (Me-Can).Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can).Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study.Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study.Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study.Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitusThe associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studiesRisk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and womenMetabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation statusBlood pressure and risk of cancer in the European Prospective Investigation into Cancer and NutritionLinear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individualsSurvival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort studyHeight, body mass index, and prostate cancer risk and mortality by way of detection and cancer risk category
P50
Q21133654-0794515B-86A6-4714-A2C3-08C99706BB79Q30851261-16C56602-128D-43FF-862F-7A364D714A0EQ33901167-913B536D-7071-41F2-951F-702681CE5F82Q34465110-3053A4E7-B31A-45D0-B18A-19C16475C14CQ34571058-3546C364-2C35-4255-8423-5C1585955F6EQ35096812-A37E51AE-E225-477D-82F6-C6CBFDBE3458Q36107648-7AD29CD1-D2B0-42E0-937F-E927428040DDQ37394248-F5AE4660-E349-4B7A-B4EB-C8EACCA918D3Q37561605-DB795CB8-5A0D-48CB-A889-8BCE73FBA27FQ37592915-9A6CEFAC-F14E-41B7-A0D5-B1C7959321C9Q38873586-4AED662E-CA55-459A-9EE3-DCB5B6AB7DD4Q42368645-AB2B091F-A8F6-41C6-94B8-80D514B21283Q42913096-4BBA7C18-95D5-41E6-B2BF-6C03C287B57CQ42975791-9160315F-AB75-40D5-9B91-ACD6EA25C50FQ44294329-E7FF8060-F08B-477F-8D08-42207166F993Q44366740-34E8E408-CD96-432E-B339-93B79CD28A41Q44676240-40806F65-89B1-432B-81FD-35E38C70BAC1Q44970998-286DC678-808A-4CC5-B83F-E5D05EED039EQ45143067-2FEBE4C9-58D5-42F0-BF65-A52AC7F30EB9Q45176483-66FC804D-945B-4723-8E59-83179F0EE981Q45297206-E7220197-2E9D-48E3-877D-675262257F7FQ46161154-022A420C-3824-4F68-A2E4-0354B7F8BC9BQ48178978-318CE26A-AA37-46B5-AB01-B1AA5E5EFD96Q57463806-77FE546F-9DC2-47F0-86B7-F209C0F9D2AAQ63865847-B128F3EE-21C1-47BF-9533-7CA11CF70D34Q88658044-C05CBBC3-ADEC-432F-B7D1-0FF3E45DCF53Q90913355-9C73530A-2B62-4DF5-818C-E90B002F7562Q91990595-54894815-9E18-460A-B254-81D041A3EB62Q91993920-9E7717C0-72FE-4471-AF73-8FEC738C5933Q92778018-F427D3F4-7B77-4C82-83C4-60A4BEA9DC90Q96290990-B084DAEA-0503-4F42-89D3-BC80FBC51A05
P50
description
Zweeds onderzoekster
@nl
researcher ORCID ID = 0000-0001-6808-4405
@en
name
Christel Häggström
@ast
Christel Häggström
@en
Christel Häggström
@es
Christel Häggström
@nl
Christel Häggström
@sl
type
label
Christel Häggström
@ast
Christel Häggström
@en
Christel Häggström
@es
Christel Häggström
@nl
Christel Häggström
@sl
prefLabel
Christel Häggström
@ast
Christel Häggström
@en
Christel Häggström
@es
Christel Häggström
@nl
Christel Häggström
@sl
P106
P21
P27
P31
P496
0000-0001-6808-4405